Recent Company News

• 03:45 AM ET Aug 26, 2026
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (19 total)

• 11:39 PM ET Aug 25, 2026
  

  StreetAccount Summary - Trading higher/lower: Hong Kong mid-morning

• 11:22 PM ET Aug 25, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (43 total)

• 11:21 PM ET Aug 25, 2026
  

  StreetAccount Summary - Trading higher/lower: Asia mid-morning

• 06:05 AM ET Aug 25, 2026
  

  Innovent Biologics reports H1 adjusted net income CNY1.70B, +40% vs year-ago CNY1.21B (HK$100.10, 0.00)

• 12:42 AM ET Aug 25, 2026
  

  Innovent Biologics resumed buy at Sinolink Securities (pre-open) (HK$100.60, +1.10)

• 08:28 AM ET Aug 19, 2026
  

  Innovent Biologics reinstated buy at DBS Group (HK$98.25, 0.00)

• 11:54 PM ET Aug 18, 2026
  

  StreetAccount Summary - Hong Kong unusual volume traders

• 12:11 AM ET Aug 06, 2026
  

  StreetAccount Sector Summary - China Healthcare July Recap

• 08:09 PM ET Aug 05, 2026
  

  Innovent Biologics doses first patient in study evaluating IBI363 in combination with bevacizumab in patients with advanced CRC (HK$90.30, 0.00)